Its triple mechanism makes it particularly valuable for studying receptor crosstalk between GIP, GLP-1, and glucagon signalling pathways, and for examining how combined incretin and glucagon receptor activation modulates metabolic outcomes that single- and dual-agonist molecules cannot replicate
Pay attention to changes over time
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS
Looking ahead, further research should aim to define the most effective combinations of pharmacotherapy and lifestyle interventions, with a focus on preserving lean mass and sustaining long-term metabolic health
Theyre experiencing something that looks like a shift in the underlying signaling environment
They may serve as adjuncts but should not be considered first-line weight loss peptides based on current evidence